insights_auto
Why is INO down 2,10%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,40 $
arrow_downward
-2,10%(-0,030) 1D
1,39 $
arrow_downward
-0,71% (-0,0100)bedtimeAfter hours
Closed: 16 қар., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,42 $
High
1,48 $
Low
1,37 $
Mkt. cap
262,23 млн
Avg. vol.
19,34 млн
Volume
6,49 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
Open
1,42 $
High
1,48 $
Low
1,37 $
Mkt. cap
262,23 млн
Avg. vol.
19,34 млн
Volume
6,49 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 млн
No. of employees
112
News stories
From web sources and news partners
Investing.com
·
15 минут бұрын
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
The Motley Fool
·
1 сағат бұрын
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
24/7 Wall St.
·
39 минут бұрын
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
ChartMill
·
1 сағат бұрын
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc